DiaMedica Therapeutics (DMAC) Other Non-Current Assets (2017 - 2026)
DiaMedica Therapeutics (DMAC) reported Other Non-Current Assets of $400000.0 for Q1 2026, little changed quarter-over-quarter from $400000.0 in Q4 2025.
DiaMedica Therapeutics (DMAC) Other Non-Current Assets (2017 - 2026) Analysis & Trends
DiaMedica Therapeutics has reported Other Non-Current Assets for 6 years, with the latest figure at $400000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Assets changed N/A year-over-year to $400000.0; the trailing twelve-month figure through Mar 2026 stood at $400000.0 (changed N/A YoY), and the FY2025 full-year result was $400000.0, down 69.42% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $400000.0, roughly flat from $400000.0 in the prior quarter.
- The five-year high for Other Non-Current Assets was $1.3 million in Q1 2024, with the low at $400000.0 in Q4 2025.
- Historically, Other Non-Current Assets has averaged $1.0 million across 3 years, with a median of $1.3 million in 2024.
- The largest YoY upside for Other Non-Current Assets was 69.42% in 2025 against a maximum downside of 69.42% in 2025.
- DiaMedica Therapeutics' Other Non-Current Assets stood at $1.3 million in 2024, then tumbled by 69.42% to $400000.0 in 2025, then changed by 0.0% to $400000.0 in 2026.
- The last three Other Non-Current Assets figures came in at $400000.0 (Q1 2026), $400000.0 (Q4 2025), and $1.3 million (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 60,000.00 |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | DiaMedica Therapeutics | 285.11 Mn | 233.77 Mn | - | 400,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 400,000.00 |
| Dec 31, 2025 | 400,000.00 |
| Dec 31, 2024 | 1.31 Mn |
| Sep 30, 2024 | 1.31 Mn |
| Jun 30, 2024 | 1.31 Mn |
| Mar 31, 2024 | 1.31 Mn |
| Jun 30, 2019 | 271,000.00 |
| Mar 31, 2019 | 271,000.00 |
| Dec 31, 2018 | 271,000.00 |
| Dec 31, 2017 | 271,000.00 |